Photodynamic Therapy News and Research

RSS
Novel microwave-induced photodynamic therapy could target deeply situated tumors

Novel microwave-induced photodynamic therapy could target deeply situated tumors

Novel therapy offers hope for effective treatment of intractable metastatic cancers

Novel therapy offers hope for effective treatment of intractable metastatic cancers

Scientists develop novel multifunctional platform to integrate imaging and photo-induced cancer therapy

Scientists develop novel multifunctional platform to integrate imaging and photo-induced cancer therapy

Soligenix announces encouraging preliminary results of heat stable Ebola vaccine

Soligenix announces encouraging preliminary results of heat stable Ebola vaccine

Photodynamic therapy effective in treating porphyrias but can be severely painful, cause inflammation

Photodynamic therapy effective in treating porphyrias but can be severely painful, cause inflammation

Clinical study finds two topical skin creams as effective noninvasive treatments for low-risk superficial BCC

Clinical study finds two topical skin creams as effective noninvasive treatments for low-risk superficial BCC

NEI-funded study analyzes outcomes of anti-VEGF therapy for AMD

NEI-funded study analyzes outcomes of anti-VEGF therapy for AMD

New photo-switchable molecule for PDT could help treat rapidly growing tumors

New photo-switchable molecule for PDT could help treat rapidly growing tumors

Combining photoimmunotherapy and gene transduction effective against elusive gastric cancer cells

Combining photoimmunotherapy and gene transduction effective against elusive gastric cancer cells

Combining nanomedicine with two anticancer treatments could improve outcomes for pancreatic cancer patients

Combining nanomedicine with two anticancer treatments could improve outcomes for pancreatic cancer patients

NSCLC treatments market in Europe expected to cross US$ 3 billion by 2019

NSCLC treatments market in Europe expected to cross US$ 3 billion by 2019

Soligenix reports positive results from SGX942 Phase 2 trial in patients with head and neck cancer

Soligenix reports positive results from SGX942 Phase 2 trial in patients with head and neck cancer

New combination approach to eradicate established tumors

New combination approach to eradicate established tumors

Soligenix completes enrolment in SGX942 Phase 2 trial for oral mucositis in cancer patients

Soligenix completes enrolment in SGX942 Phase 2 trial for oral mucositis in cancer patients

Soligenix obtains additional funding from NIAID to advance development of OrbeShield for GI ARS treatment

Soligenix obtains additional funding from NIAID to advance development of OrbeShield for GI ARS treatment

NIAID exercises option to advance development of Soligenix's heat stabilized ricin toxin vaccine

NIAID exercises option to advance development of Soligenix's heat stabilized ricin toxin vaccine

Researchers use advanced photodynamic therapy to combat ovarian cancer in laboratory animals

Researchers use advanced photodynamic therapy to combat ovarian cancer in laboratory animals

European Commission grants orphan drug designation to SGX301 for treatment of CTCL

European Commission grants orphan drug designation to SGX301 for treatment of CTCL

Soligenix signs $10M equity purchase agreement with accredited institutional investors

Soligenix signs $10M equity purchase agreement with accredited institutional investors

Current and new treatments for AMD: an interview with Dr Alan Cruess, AMD Alliance International

Current and new treatments for AMD: an interview with Dr Alan Cruess, AMD Alliance International